Nazanin Mirzaei, PhD, completed her postgraduate education at Imperial College London, United Kingdom, where she received her master's of research in experimental neuroscience and her doctorate in neuroscience/neuropsychopharmacology with a focus on Alzheimer's disease. She uses multidisciplinary approaches to study the underlying pathology and role of inflammation in neurodegenerative disorders as well as to assess efficacy of potential therapeutic interventions. After moving to California, she joined the Koronyo-Hamaoui Lab as a postdoctoral researcher to further characterize and map retinal neuropathology and to study the role of immune responses and modulation in Alzheimer's disease.
Haoshen Shi, MD, PhD, completed his medical education in Shandong, China. He then moved to Detroit to pursue his scientific education as a doctoral student in the Anatomy & Cell Biology department at Wayne State University School of Medicine. Dr. Shi is an eye specialist with research experience in immunology and diabetic retinopathy. He is now undertaking new research on retinal vasculature in Alzheimer's disease in the Koronyo-Hamaoui lab.
Altan Rentsendorj, PhD, received her Master of Science in Microbiology and her Doctorate in Molecular Biology at Lorand Eotvos University, Budapest and the Hungarian Academy of Sciences, Szeged, respectively. She was a research fellow at the Institute of Biotechnology, Mongolian Academy of Sciences, Ulaanbaatar; a postdoctoral fellow in biology at St. Luke's Medical Center, Rush Presbyterian Hospital, Chicago, IL, and in virology at City of Hope Medical Center, Beckman Research Institute, Duarte, CA; a scientist at the University of Southern California, Norris Cancer Center, Gene Therapy Laboratories; and is a research associate at Cedars-Sinai Medical Center, Department of Neurosurgery, Regenerative Medicine Institute.
Yosef Koronyo, MSc, LLB, received his Bachelor of Science in Natural Sciences and his Master of Science in Molecular Microbiology and Biotechnology at Tel-Aviv University, Israel. He was a researcher at Wise Faculty of Life Sciences, Tel-Aviv University. In parallel with his PhD studies in plant genetic engineering, he studied law at Tel-Aviv University, eventually shifting completely into law studies and becoming a member of the Israeli bar. During the past six years, Koronyo has shifted back to biological research. He developed exclusive noninvasive imaging approaches for ex vivo and in vivo monitoring of pathological processes and immune cell infiltration in the retina of rodent models of neurodegenerative disorders.
Giovanna Regis received her bachelor's degree in Neuroscience & Behavior from Barnard College at Columbia University. She is currently working as a research intern at the Koronyo-Hamaoui Laboratory conducting Alzheimer's disease research in immune therapies and retinal pathology.
Dieu-Trang (Sandrine) Fuchs, MSc, received her Master of Science in Biology from the Pierre and Marie Curie University, Paris, France and her Medical Analysis certification from the Pitie-Salpetriere Hospital, Paris, France. Since joining the Koronyo-Hamaoui Laboratory, Fuchs has been involved in studying the pathological and behavioral aspects of Alzheimer's disease following immune-based therapies in transgenic mouse models.
Julia Sheyn, BSc, completed her Bachelor of Science in Pharmacy at the Hebrew University of Jerusalem, Faculty of Medicine. She worked for two years as a research assistant in a pharmaceutics lab at the Hebrew University Pharmacy School and for a year in the Heart Institute at the Hadassah University Hospital, Jerusalem. After graduation from pharmacy school, Sheyn worked as a community pharmacist for 7 years. She has been involved in neuropathological assessments as well as cognitive and behavioral testing following immune-modulation therapies in transgenic mouse models of disease.
Jonah Doustar earned his bachelor's degree in neuroscience from Boston University and is currently a pre-medical student. In the Koronyo-Hamaoui lab, he is researching the effects of late-stage immune-modulation treatment on Alzheimer's neuropathies as well as retinal pathology in transgenic murine models of Alzheimer's disease.
Tania Torbati is a Magna Cum Laude Bachelor of Science graduate from UCLA in Psychobiology. She is currently interning in the Koronyo-Hamaoui lab while attending medical school at Western University of Health Sciences in Pomona, California. Tania’s work in the lab focuses on retinal detection of Alzheimer's disease in addition to reduction of neuropathology in response to immunomodulation. She is a four-time winner of 1st place poster/oral presentations at UCLA, CSMC, and other scientific conferences.
Mia Oviatt received her bachelor's degree in Biology with a concentration in Neurobiology from the California Institute of Technology, where she studied the neural circuitry of food anticipation in mice in the Steele Lab. She now supports the Koronyo-Hamaoui Laboratory in an administrative role, assisting with grant applications, tracking financials, organizing events, editing scientific content, and overseeing communications.
Cedars-Sinai Maxine Dunitz Neurosurgical Institute
127 S. San Vicente Blvd.
Advanced Health Science Pavilion, Eighth Floor, Suite A8103
Los Angeles, CA 90048